Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|September 13, 2011
Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trialSusan A Jebb, Amy L Ahern, Ashley D Olson, et al.
Rheumatology (Oxford, England)|February 26, 2010
Numerical scoring for the BILAG-2004 indexChee-Seng Yee, Lynne Cresswell, Vernon Farewell, et al.
Frontiers in Molecular Neuroscience|September 4, 2024
C286, an orally available retinoic acid receptor β agonist drug, regulates multiple pathways to achieve spinal cord injury repairMaria B Goncalves, Yue Wu, Earl Clarke, et al.
BMC Medicine|March 2, 2018
Adaptive designs in clinical trials: why use them, and how to run and report themPhilip Pallmann, Alun W Bedding, Babak Choodari-Oskooei, et al.
JCI Insight|October 5, 2018
The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetesEleonora Seelig, James Howlett, Linsey Porter, et al.
Rheumatology (Oxford, England)|September 26, 2009
Numerical scoring for the Classic BILAG indexLynne Cresswell, Chee-Seng Yee, Vernon Farewell, et al.
BMC Medicine|November 17, 2018
Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive designMunyaradzi Dimairo, Elizabeth Coates, Philip Pallmann, et al.
Pageof 9